Can vascular endothelial growth factor and microvessel density be used as prognostic biomarkers for colorectal cancer? A systematic review and meta-analysis

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Wang, Yibaina ^a   Yao, Xiaoping ^a   Ge, Jie ^a   Hu, Fulan ^a   Zhao, Yashuang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; VASCULOTROPIN; VASCULOTROPIN A;

CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CAPILLARY DENSITY; CHEMOTHERAPY; CLINICAL FEATURE; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; META ANALYSIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; REVIEW; SYSTEMATIC REVIEW; COLORECTAL NEOPLASMS; METABOLISM; MICROVASCULATURE; PATHOLOGY; PROGNOSIS;

BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; HUMANS; MICROVESSELS; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899445061     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/102736     Document Type: Review

References (84)

1. Barresi V., di Gregorio C., Regiani-Bonetti L., Ponz-de Leon M., Barresi G., Vitarelli E., Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome. Virchows Archiv 2010 457 1 11 19 2-s2.0-77954565320 10.1007/s00428-010-0933-5
2. Ferrara N., VEGF and the quest for tumour angiogenesis factors. Nature Reviews Cancer 2002 2 10 795 803 2-s2.0-0036782278 10.1038/nrc909
3. Yodavudh S., Tangjitgamol S., Puangsa-art S., Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer. Journal of the Medical Association of Thailand 2008 91 5 723 732 2-s2.0-44649104523
4. Leung D. W., Cachianes G., Kuang W.-J., Goeddel D. V., Ferrara N., Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989 246 4935 1306 1309 2-s2.0-0024818355
5. Guba M., Seeliger H., Kleespies A., Jauch K.-W., Bruns C., Vascular endothelial growth factor in colorectal cancer. International Journal of Colorectal Disease 2004 19 6 510 517 2-s2.0-7444260919 10.1007/s00384-003-0576-y
6. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., Berlin J., Baron A., Griffing S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross R., Kabbinavar F., Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. The New England Journal of Medicine 2004 350 23 2335 2342 2-s2.0-2542561964 10.1056/NEJMoa032691
7. Saltz L. B., Clarke S., Díaz-Rubio E., Scheithauer W., Figer A., Wong R., Koski S., Lichinitser M., Yang T.-S., Rivera F., Couture F., Sirzén F., Cassidy J., Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. Journal of Clinical Oncology 2008 26 12 2013 2019 2-s2.0-42949149159 10.1200/JCO.2007.14.9930
8. Giantonio B. J., Catalano P. J., Meropol N. J., O'Dwyer P. J., Mitchell E. P., Alberts S. R., Schwartz M. A., Benson A. B. III, Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. Journal of Clinical Oncology 2007 25 12 1539 1544 2-s2.0-34248173883 10.1200/JCO.2006.09.6305
9. Kabbinavar F. F., Schulz J., McCleod M., Patel T., Hamm J. T., Hecht J. R., Mass R., Perrou B., Nelson B., Novotny W. F., Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. Journal of Clinical Oncology 2005 23 16 3697 3705 2-s2.0-20544478429 10.1200/JCO.2005.05.112
10. Des Guetz G., Uzzan B., Nicolas P., Cucherat M., Morere J.-F., Benamouzig R., Breau J.-L., Perret G.-Y., Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. British Journal of Cancer 2006 94 12 1823 1832 2-s2.0-33745102388 10.1038/sj.bjc.6603176
11. Spruance S. L., Reid J. E., Grace M., Samore M., Hazard ratio in clinical trials. Antimicrobial Agents and Chemotherapy 2004 48 8 2787 2792 2-s2.0-3343026143 10.1128/AAC.48.8.2787-2792.2004
12. Steels E., Paesmans M., Berghmans T., Branle F., Lemaitre F., Mascaux C., Meert A. P., Vallot F., Lafitte J. J., Sculier J. P., Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. European Respiratory Journal 2001 18 4 705 719 2-s2.0-17944380542 10.1183/09031936.01.00062201
13. Uzzan B., Nicolas P., Cucherat M., Perret G.-Y., Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Research 2004 64 9 2941 2955 2-s2.0-2342514123 10.1158/0008-5472.CAN-03-1957
14. DerSimonian R., Laird N., Meta-analysis in clinical trials. Controlled Clinical Trials 1986 7 3 177 188 2-s2.0-0022992740
15. Begg C. B., Mazumdar M., Operating characteristics of a rank correlation test for publication bias. Biometrics 1994 50 4 1088 1101 2-s2.0-0028659004 10.2307/2533446
16. Boxer G. M., Tsiompanou E., Levine T., Watson R., Begent R. H. J., Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer. Tumor Biology 2005 26 1 1 8 2-s2.0-17244380985 10.1159/000084180
17. Cianchi F., Palomba A., Messerini L., Boddi V., Asirelli G., Perigli G., Bechi P., Taddei A., Pucciani F., Cortesini C., Tumor angiogenesis in lymph node-negative rectal cancer: correlation with clinicopathological parameters and prognosis. Annals of Surgical Oncology 2002 9 1 20 26 2-s2.0-0036205752 10.1245/aso.2002.9.1.20
18. Hong Y. S., Cho H. J., Kim S. Y., Jung K. H., Park J. W., Choi H. S., Oh J. H., Kim B. C., Sohn D. K., Kim D. Y., Chang H. J., Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer. BMC cancer 2009 9, article 246 2-s2.0-73349143677 10.1186/1471-2407-9-246
19. Giralt J., Navalpotro B., Hermosilla E., De Torres I., Espin E., Reyes V., Cerezo L., De Las Heras M., Ramon Y Cajal S., Armengol M., Benavente S., Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy. Oncology 2006 71 5-6 312 319 2-s2.0-35348851655 10.1159/000107105
20. Miyagawa S., Miwa S., Soeda J., Kobayashi A., Kawasaki S., Morphometric analysis of liver macrophages in patients with colorectal liver metastasis. Clinical and Experimental Metastasis 2002 19 2 119 125 2-s2.0-0036201992 10.1023/A:1014571013978
21. Chung Y.-C., Hou Y.-C., Chang C.-N., Hseu T.-H., Expression and prognostic significance of angiopoietin in colorectal carcinoma. Journal of Surgical Oncology 2006 94 7 631 638 2-s2.0-33845188987 10.1002/jso.20423
22. Rajaganeshan R., Jayne D. G., Malik H. Z., Scott N., Lodge J. P. A., Toogood G. J., Prasad K. R., Biological characteristics and behaviour of putatively curatively resected colorectal liver metastases. European Journal of Surgical Oncology 2008 34 4 439 444 2-s2.0-40749089975 10.1016/j.ejso.2007.03. 017
23. Nanashima A., Shibata K., Nakayama T., Tobinaga S., Araki M., Kunizaki M., Takeshita H., Hidaka S., Sawai T., Nagayasu T., Yasutake T., Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma. Annals of Surgical Oncology 2009 16 8 2130 2137 2-s2.0-67650995763 10.1245/s10434-009-0459-8
24. Toiyama Y., Inoue Y., Saigusa S., Okugawa Y., Yokoe T., Tanaka K., Miki C., Kusunoki M., Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery. Clinical Oncology 2010 22 4 272 280 2-s2.0-77951766722 10.1016/j.clon.2010.01.001
25. Wei S.-C., Liang J.-T., Tsao P.-N., Hsieh F.-J., Yu S.-C., Wong J.-M., Preoperative serum placenta growth factor level is a prognostic biomarker in colorectal cancer. Diseases of the Colon and Rectum 2009 52 9 1630 1636 2-s2.0-70249090040 10.1007/DCR.0b013e3181afbdaf
26. Kwon K. A., Kim S. H., Oh S. Y., Lee S., Han J.-Y., Kim K. H., Goh R. Y., Choi H. J., Park K. J., Roh M. S., Kim H.-J., Kwon H.-C., Lee J. H., Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer 2010 10, article 203 2-s2.0-77952085846 10.1186/1471-2407-10-203
27. Miyazaki T., Okada N., Ishibashi K., Ogata K., Ohsawa T., Ishiguro T., Nakada H., Yokoyama M., Matsuki M., Kato H., Kuwano H., Ishida H., Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer. Japanese Journal of Clinical Oncology 2008 38 12 839 843 2-s2.0-57249084765 10.1093/jjco/hyn106
28. Ishigami S.-I., Arii S., Furutani M., Niwano M., Harada T., Mizumoto M., Mori A., Onodera H., Imamura M., Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. British Journal of Cancer 1998 78 10 1379 1384 2-s2.0-0031789314
29. Cao D., Hou M., Guan Y.-S., Jiang M., Yang Y., Gou H.-F., Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer 2009 9, article 432 2-s2.0-73249130655 10.1186/1471-2407-9-432
30. Ferroni P., Spila A., Martini F., D'Alessandro R., Mariotti S., Del Monte G., Graziano P., Buonomo O., Guadagni F., Roselli M., Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer. Oncology 2005 69 2 145 153 2-s2.0-25444461145 10.1159/000087838
31. Liang J.-F., Wang H.-K., Xiao H., Li N., Cheng C.-X., Zhao Y.-Z., Ma Y.-B., Gao J.-Z., Bai R.-B., Zheng H.-X., Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer. Journal of Experimental and Clinical Cancer Research 2010 29 1, article 71 2-s2.0-77953511554 10.1186/1756-9966-29-71
32. Kaio E., Tanaka S., Kitadai Y., Sumii M., Yoshihara M., Haruma K., Chayama K., Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma. Oncology 2003 64 1 61 73 2-s2.0-18744412350 10.1159/000066511
33. Khorana A. A., Ryan C. K., Cox C., Eberly S., Sahasrabudhe D. M., Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with stage II and stage III colon carcinoma: a role for the host response in prognosis. Cancer 2003 97 4 960 968 2-s2.0-0037441914 10.1002/cncr.11152
34. Tamura M., Oda M., Tsunezuka Y., Matsumoto I., Kawakami K., Watanabe G., Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor. Journal of Thoracic and Cardiovascular Surgery 2004 128 4 517 522 2-s2.0-4644371867 10.1016/j.jtcvs. 2004.03.056
35. White J. D., Hewett P. W., Kosuge D., McCulloch T., Enholm B. C., Carmichael J., Murray J. C., Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Research 2002 62 6 1669 1675 2-s2.0-0037086278
36. Kojima M., Shiokawa A., Ohike N., Ohta Y., Kato H., Iwaku K., Hayasi R., Morohoshi T., Clinical significance of nuclear morphometry at the invasive front of T1 colorectal cancer and relation to expression of VEGF-A and VEGF-C. Oncology 2005 68 2-3 230 238 2-s2.0-23844496847 10.1159/000086779
37. Alabi A. A., Suppiah A., Madden L. A., Monson J. R., Greenman J., Preoperative serum vascular endothelial growth factor-A is a marker for subsequent recurrence in colorectal cancer patients. Diseases of the Colon and Rectum 2009 52 5 993 999 2-s2.0-67651183805 10.1007/DCR.0b013e31819ed3bc
38. Zhou Z.-G., Wu X.-J., Li L.-R., Peng Z.-H., Ding P.-R., Wang R.-J., Pan Z.-Z., A multivariate analysis of prognostic determinants for stages II and III colorectal cancer in 141 patients. Chinese Medical Journal 2011 124 14 2132 2135 2-s2.0-79960682149 10.3760/cma.j.issn.0366-6999.2011.14.010
39. Zafirellis K., Agrogiannis G., Zachaki A., Gravani K., Karameris A., Kombouras C., Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer. Journal of Surgical Research 2008 147 1 99 107 2-s2.0-43049147668 10.1016/j.jss.2007.05.041
40. Chen J., Li Q., Wang C., Wu J., Zhao G., Prognostic significance of c-erbb-2 and vascular endothelial growth factor in colorectal liver metastases. Annals of Surgical Oncology 2010 17 6 1555 1563 2-s2.0-77954814875 10.1245/s10434-009-0897-3
41. Zhang C., Hao L., Wang L., Xiao Y., Ge H., Zhu Z., Luo Y., Zhang Y., Zhang Y., Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer. BMC Cancer 2010 10, article 184 2-s2.0-77951954900 10.1186/1471-2407-10-184
42. Lin M., Lin H.-Z., Ma S.-P., Ji P., Xie D., Yu J.-X., Vascular endothelial growth factor-A and -C: expression and correlations with lymphatic metastasis and prognosis in colorectal cancer. Medical Oncology 2011 28 1 151 158 2-s2.0-79952252008 10.1007/s12032-010-9427-1
43. Amaya H., Tanigawa N., Lu C., Matsumura M., Shimomatsuya T., Horiuchi T., Muraoka R., Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer. Cancer Letters 1997 119 2 227 235 2-s2.0-0030700901 10.1016/S0304-3835(97)00280-2
44. Harada Y., Ogata Y., Shirouzu K., Expression of vascular endothelial growth factor and its receptor KDR (kinase domain-containing receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer. International Journal of Clinical Oncology 2001 6 5 221 228 2-s2.0-0035201545
45. Lee J.-C., Chow N.-H., Wang S.-T., Huang S.-M., Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. European Journal of Cancer 2000 36 6 748 753 2-s2.0-0034075041 10.1016/S0959-8049(00)00003-4
46. Zheng S., Han M.-Y., Xiao Z.-X., Peng J.-P., Dong Q., Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World Journal of Gastroenterology 2003 9 6 1227 1230 2-s2.0-0037713738
47. Ochs A.-M., Wong L., Kakani V., Neerukonda S., Gorske J., Rao A., Riggs M., Ward H., Keville L., Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival. Clinical Colorectal Cancer 2004 4 4 262 267 2-s2.0-10944257660
48. Kang S. M., Maeda K., Onoda N., Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. International Journal of Cancer 1997 74 502 507
49. Theodoropoulos G. E., Lazaris A. C., Theodoropoulos V. E., Papatheodosiou K., Gazouli M., Bramis J., Patsouris E., Panoussopoulos D., Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. International Journal of Colorectal Disease 2006 21 3 248 257 2-s2.0-33244495520 10.1007/s00384-005-0788-4
50. Shinji S., Naito Z., Ishiwata T., Tanaka N., Furukawa K., Suzuki H., Seya T., Kan H., Tsuruta H., Matsumoto S., Matsuda A., Teranishi N., Ohaki Y., Tajiri T., Neuroendocrine cell differentiation of poorly differentiated colorectal adenocarcinoma correlates with liver metastasis. International Journal of Oncology 2006 29 2 357 364 2-s2.0-33747611561
51. Kaio E., Tanaka S., Oka S., Hiyama T., Kitadai Y., Haruma K., Chayama K., Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma. International Journal of Oncology 2003 23 4 901 911 2-s2.0-3042511800
52. Jubb A. M., Hurwitz H. I., Bai W., Holmgren E. B., Tobin P., Guerrero A. S., Kabbinavar F., Holden S. N., Novotny W. F., Frantz G. D., Hillan K. J., Koeppen H., Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer. Journal of Clinical Oncology 2006 24 2 217 227 2-s2.0-33644823334 10.1200/JCO.2005.01.5388
53. Moreira L. R., Schenka A. A., Latuf-Filho P., Penná A. L., Lima C. S. P., Soares F. A., Silva Trevisan M. A., Vassallo J., Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors. Tumor Biology 2011 32 3 527 534 2-s2.0-79960593149 10.1007/s13277-010-0147-0
54. Gulubova M., Vlaykova T., Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. Journal of Gastroenterology and Hepatology 2009 24 7 1265 1275 2-s2.0-68749085163 10.1111/j.1440-1746.2007.05009.x
55. Vermeulen P. B., van den Eynden G. G., Huget P., Goovaerts G., Weyler J., Lardon F., Van Marck E., Hubens G., Dirix L. Y., Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. British Journal of Cancer 1999 79 2 316 322 2-s2.0-0032919961 10.1038/sj.bjc.6690051
56. Sternfeld T., Foss H. D., Kruschewski M., Runkel N., The prognostic significance of tumor vascularization in patients with localized colorectal cancer. International Journal of Colorectal Disease 1999 14 6 272 276 2-s2.0-0033383440
57. Tanigawa N., Amaya H., Matsumura M., Lu C., Kitaoka A., Matsuyama K., Muraoka R., Tumor anglogenesis and mode of metastasis in patients with colorectal cancer. Cancer Research 1997 57 6 1043 1046 2-s2.0-0030615084
58. Romani A. A., Borghetti A. F., del Rio P., Sianesi M., Soliani P., The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count. Journal of Surgical Oncology 2006 93 6 446 455 2-s2.0-33646828741 10.1002/jso.20456
59. Takebayashi Y., Akiyama S. I., Akiba S., Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. Journal of the National Cancer Institute 1996 88 1110 1117
60. Hasebe T., Sasaki S., Sugitoh M., Ono M., Saitoh N., Ochiai A., Proliferative activities of tumor stromal cells play important roles in tumor thickness and progression of T3 ulcerative-type colorectal cancer. Virchows Archiv 2003 442 6 569 576 2-s2.0-0038008281
61. Svagzdys S., Lesauskaite V., Pavalkis D., Nedzelskiene I., Pranys D., Tamelis A., Microvessel density as new prognostic marker after radiotherapy in rectal cancer. BMC Cancer 2009 9, article 95 2-s2.0-64749092297 10.1186/1471-2407-9-95
62. Yan G., Zhou X.-Y., Cai S.-J., Zhang G.-H., Peng J.-J., Du X., Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma. World Journal of Gastroenterology 2008 14 1 101 107 2-s2.0-39849101920 10.3748/wjg.14.101
63. Yonenaga Y., Mori A., Onodera H., Yasuda S., Oe H., Fujimoto A., Tachibana T., Imamura M., Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology 2005 69 2 159 166 2-s2.0-25444491756 10.1159/000087840
64. Tarta C., Teixeira C. R., Tanaka S., Haruma K., Chiele-Neto C., da Silva V. D., Angiogenesis in advanced colorectal adenocarcinoma with special reference to tumoral invasion. Arquivos de Gastroenterologia 2002 39 1 32 38 2-s2.0-0036044517
65. Pietra N., Sarli L., Caruana P., Cabras A., Costi R., Gobbi S., Bordi C., Peracchia A., Is tumour angiogenesis a prognostic factor in patients with colorectal cancer and no involved nodes? European Journal of Surgery 2000 166 7 552 556 2-s2.0-0033929041
66. Choi H. J., Hyun M. S., Jung G. J., Kim S. S., Hong S. H., Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 1998 55 6 575 581 2-s2.0-0031727144 10.1159/000011915
67. Tomisaki S., Ohno S., Ichiyoshi Y., Kuwano H., Maehara Y., Sugimachi K., Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 1996 77 1722 1728 10.1002/(SICI)1097-0142(19960415)77: 8<1722::AID-CNCR46>3.0.CO;2-Z
68. Minagawa N., Nakayama Y., Hirata K., Onitsuka K., Inoue Y., Nagata N., Itoh H., Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer. Anticancer Research 2002 22 5 2957 2964 2-s2.0-0036765665
69. Takebayashi Y., Akiyama S. I., Yamada K., Akiba S., Aikou T., Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 1996 78 226 231
70. Sharifi N., Ghaffarzadegan K., Ayatollahi H., Shakeri M. T., Sadeghian M. H., Azari J. B., Evaluation of angiogenesis in colorectal carcinoma by CD34 immunohistochemistry method and its correlation with clinicopathologic parameters. Acta Medica Iranica 2009 47 3 161 164 2-s2.0-72049089283
71. Rasheed S., Harris A. L., Tekkis P. P., Turley H., Silver A., McDonald P. J., Talbot I. C., Glynne-Jones R., Northover J. M. A., Guenther T., Assessment of microvessel density and carbonic anhydrase-9 (CA-9) expression in rectal cancer. Pathology Research and Practice 2009 205 1 1 9 2-s2.0-57249103323 10.1016/j.prp.2008.08.008
72. Teranishi N., Naito Z., Ishiwata T., Tanaka N., Furukawa K., Seya T., Shinji S., Tajiri T., Identification of neovasculature using nestin in colorectal cancer. International Journal of Oncology 2007 30 3 593 603 2-s2.0-33947729718
73. Nanashima A., Ito M., Sekine I., Naito S., Yamaguchi H., Nakagoe T., Ayabe H., Significance of angiogenic factors in liver metastatic tumors originating from colorectal cancers. Digestive Diseases and Sciences 1998 43 12 2634 2640 2-s2.0-0032412517 10.1023/A:1026643009152
74. Acikalin M. F., Öner Ü., Topçu I., Yaşar B., Kiper H., Çolak E., Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Digestive and Liver Disease 2005 37 3 162 169 2-s2.0-22844435648 10.1016/j.dld.2004.09.028
75. Zhan P., Wang J., Lv X.-J., Wang Q., Qiu L.-X., Lin X.-Q., Yu L.-K., Song Y., Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis. Journal of Thoracic Oncology 2009 4 9 1094 1103 2-s2.0-69549084550 10.1097/JTO. 0b013e3181a97e31
76. Smith R. A., Tang J., Tudur-Smith C., Neoptolemos J. P., Ghaneh P., Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. British Journal of Cancer 2011 104 9 1440 1451 2-s2.0-79955472083 10.1038/bjc.2011.110
77. Schoenleber S. J., Kurtz D. M., Talwalkar J. A., Roberts L. R., Gores G. J., Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis. British Journal of Cancer 2009 100 9 1385 1392 2-s2.0-65549105393 10.1038/sj.bjc.6605017
78. Chen J., Li T., Wu Y., He L., Zhang L., Shi T., Yi Z., Liu M., Pang X., Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis. Journal of Cancer Research and Clinical Oncology 2011 137 12 1799 1812 2-s2.0-82955165140 10.1007/s00432-011-1057-2
79. Ferrara N., Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 2004 25 4 581 611 2-s2.0-4143136640 10.1210/er.2003-0027
80. Presta L. G., Chen H., O'Connor S. J., Chisholm V., Meng Y. G., Krummen L., Winkler M., Ferrara N., Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Research 1997 57 20 4593 4599 2-s2.0-0030856731
81. Hurwitz H., Integrating the anti-VEGF-a humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer. Clinical Colorectal Cancer 2004 4 supplement 2 S62 S68 2-s2.0-7444224685
82. Saltz L., Management of metastatic colorectal cancer: the impact of clinical trials reported at ASCO 2007. Community Oncology 2008 5 1 37 42 2-s2.0-38949110269
83. Kabbinavar F. F., Hambleton J., Mass R. D., Hurwitz H. I., Bergsland E., Sarkar S., Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. Journal of Clinical Oncology 2005 23 16 3706 3712 2-s2.0-20544471876 10.1200/JCO.2005.00.232
84. Cao Y., Tan A., Gao F., Liu L., Liao C., Mo Z., A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer. International Journal of Colorectal Disease 2009 24 6 677 685 2-s2.0-67349286163 10.1007/s00384-009-0655- 9